Pharmaceutical composition for the treatment of cancer

The present disclosure discloses a pharmaceutical composition comprising compound of Formula I, Formula II, Formula III, Formula IV, and their pharmaceutically acceptable salts, analogs, tautomeric forms, stereoisomers, geometrical isomers, polymorphs, hydrates, solvates, metabolites, and prodrugs t...

Full description

Saved in:
Bibliographic Details
Main Authors MOOKHTIAR, Kasim, MERU, Ashwin, BASU, Sujay, ROUDURI, Sreekanth
Format Patent
LanguageEnglish
Published 19.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure discloses a pharmaceutical composition comprising compound of Formula I, Formula II, Formula III, Formula IV, and their pharmaceutically acceptable salts, analogs, tautomeric forms, stereoisomers, geometrical isomers, polymorphs, hydrates, solvates, metabolites, and prodrugs thereof, for the manufacture of a medicament for the treatment of a condition or disorder ameliorated by inhibition of the A
AbstractList The present disclosure discloses a pharmaceutical composition comprising compound of Formula I, Formula II, Formula III, Formula IV, and their pharmaceutically acceptable salts, analogs, tautomeric forms, stereoisomers, geometrical isomers, polymorphs, hydrates, solvates, metabolites, and prodrugs thereof, for the manufacture of a medicament for the treatment of a condition or disorder ameliorated by inhibition of the A
Author MOOKHTIAR, Kasim
MERU, Ashwin
ROUDURI, Sreekanth
BASU, Sujay
Author_xml – fullname: MOOKHTIAR, Kasim
– fullname: MERU, Ashwin
– fullname: BASU, Sujay
– fullname: ROUDURI, Sreekanth
BookMark eNrjYmDJy89L5WQwC8hILMpNTE4tLclMTsxRSM7PLcgvzizJzM9TSMsvUijJSFUoKUpNLMlNzStRyE9TSE7MS04t4mFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFQAPzUkviHUONDAwtjC0sjQ2NnZyMjIlUBgDlNzD1
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2018389313BB2
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2018389313BB23
IEDL.DBID EVB
IngestDate Fri Sep 27 05:25:47 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2018389313BB23
Notes Application Number: AU20180389313
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210819&DB=EPODOC&CC=AU&NR=2018389313B2
ParticipantIDs epo_espacenet_AU2018389313BB2
PublicationCentury 2000
PublicationDate 20210819
PublicationDateYYYYMMDD 2021-08-19
PublicationDate_xml – month: 08
  year: 2021
  text: 20210819
  day: 19
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies IMPETIS BIOSCIENCES LTD
RelatedCompanies_xml – name: IMPETIS BIOSCIENCES LTD
Score 3.3392522
Snippet The present disclosure discloses a pharmaceutical composition comprising compound of Formula I, Formula II, Formula III, Formula IV, and their pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Pharmaceutical composition for the treatment of cancer
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210819&DB=EPODOC&locale=&CC=AU&NR=2018389313B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED_GFN2bTsWvSR5G34q2y2r6MMR-MYRtRTbZ2-h1CQ6kHVuH_76X0s0-6Vs-ICQXLr-7Xy4XgK5MRapsoUzBhWNyAmDTfZJoqgQdqqErl5rvGI2d4Yy_zfvzBnzt38KUeUK_y-SIpFEp6XtRntfrXxIrKGMrt4-4oqb8JZoOAqPyjsl_IYQzAm8QxpNg4hu-T56kMX7XVKDQ2Gz1PDqwj7QhrTPthx-efpeyroNKdAbHMY2XFefQkFkbTv3932ttOBlVV95UrLRvewFO_FknoJkOB69irhjZnoxsOXYIHGe5Yqne0s0ldKNw6g9NmsDisN7F66w2W8_uXUEzyzN5DUxwdJEc2kToP0JwmfSfkXNUdmqhcpS8gc6fQ93-038HLS1EzZla7j00i81Odgh0C3woZfUDbSmF5A
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT4MwEL8s0zjfdGr8mvZh4Y0ojLHysBiBEdTBiGFmb4SyNpoYWDaM_75XwiZP-taPpGmvuf7ufr1eAfo8o5nQqVCpQU3VQABWrXvOVJEyE2vM4kvJdwSh6c-N58Vw0YLP7VuYKk_od5UcETUqQ30vq_N69UtiuVVs5eaOfWBT8eDFY1epvWP0XxDhFNceT6KZO3MUx0FPUglfJRVIJTZrAxsP7L2RzM8rjac3W75LWTVBxTuC_QjHy8tjaPG8Cx1n-_daFw6C-sobi7X2bU7AjN6bBDSR4eB1zBVB25OgLUd2geOkECSTW7o-hb43iR1fxQkku_Umj_PGbG19cAbtvMj5ORBqMIuhQ5tS-UcIW6bDETMMJvRMY8IU_AJ6fw51-U__LXT8OJgm06fw5QoOpUAlf6pZ19Au11-8hwBcsptKbj_YeIjR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pharmaceutical+composition+for+the+treatment+of+cancer&rft.inventor=MOOKHTIAR%2C+Kasim&rft.inventor=MERU%2C+Ashwin&rft.inventor=BASU%2C+Sujay&rft.inventor=ROUDURI%2C+Sreekanth&rft.date=2021-08-19&rft.externalDBID=B2&rft.externalDocID=AU2018389313BB2